In the Billings Gazette, Keith S. emphasizes that relying on Most Favored Nation (MFN) drug pricing models threatens future medical innovation and risks missing the root cause of high out-of-pocket costs at the pharmacy counter. Instead, Keith advocates for policymakers to enforce real accountability for insurance companies, specifically regarding passed-through savings and retained discounts, to deliver actual, direct savings to Montana patients.